| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.09 | 0.01 |